FCA's approval for amendments to instrument of incorporationU.K.
27.—(1) A protected cell company must give written notice to the FCA of a proposed amendment to the protected cell company's instrument of incorporation.
(2) Notice under paragraph (1) must be accompanied by—
(a)the proposed amendment; and
(b)a draft of the protected cell company's instrument of incorporation as amended by the proposed amendment.
(3) The FCA must approve the proposed amendment unless the proposed amendment would affect the protected cell company's compliance with the requirements of regulations 17 and 19.
(4) For the purposes of determining whether the proposed amendment will affect the protected cell company's compliance with the requirements of regulation 19, the FCA may rely on a statement signed by the solicitor or counsel for the protected cell company confirming that the proposed amendment does not affect the protected cell company's compliance with regulation 19.
(5) Effect must not be given to any proposed amendment to the protected cell company's instrument of incorporation unless—
(a)the FCA has given its approval to the proposal by notice in writing; or
(b)the FCA has failed to give the protected cell company a warning notice within a period of six weeks beginning with the date on which written notice referred to in paragraph (1) was given to the FCA.